Breaking the Cycle: A New Path Forward for Eating Disorder Treatment

Eating disorders are complex, deadly, and often intertwined with other physical and mental health challenges. NeoLumina is committed to creating a new way forward — one rooted in nature, science, and care.

Eating disorders are not just difficult — they are among the most challenging psychiatric conditions to treat, with the highest mortality rate of all mental health disorders. For many, they coexist with anxiety, depression, and physical health issues, creating a cycle that feels impossible to escape.

At NeoLumina BioScience, we believe that breaking this cycle requires a new kind of medicine — and a new kind of thinking.

That’s why we’re developing a natural, psilocybin-based therapy, enhanced by complementary active compounds, designed not just to trigger temporary shifts in brain function, but to support long-lasting healing and reconnection.

Our team brings decades of experience in product development and clinical trials, and we’re applying that expertise to transform the treatment landscape for eating disorders and beyond.

We’re building more than medicine. We’re building hope.

Because when innovation is rooted in compassion, real change begins.

Watch this message from our CEO: